ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,815.03
      0.61%
      US Tech 100
      19,700.00
      -0.02%
      Dow Jones
      42,863.86
      0.97%
      Brent Oil
      78.695
      0.00%
      Bitcoin
      62,932.87
      0.77%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Ids (MLIDS) Quote

      Ids

      Ids (MLIDS)

      EU
      0.49
      0.00
      (0.00%)
      Closed October 12 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.49
      Bid
      0.25
      Ask
      0.48
      Volume
      0.00
      0.00 Day's Range 0.00
      0.30 52 Week Range 0.68
      Market Cap
      2.35M
      Previous Close
      0.49
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      380
      Shares Outstanding
      4,796,393
      Dividend Yield
      -
      PE Ratio
      -3.64
      Earnings Per Share (EPS)
      -0.13
      Revenue
      1.79M
      Net Profit
      -646k

      About Ids

      Sector
      Computers & Software-whsl
      Industry
      Computers & Software-whsl
      Website
      www.idsfrance.com
      Headquarters
      Lyon, Rhone, Fra
      Founded
      -
      Ids is listed in the Computers & Software-whsl sector of the Euronext with ticker MLIDS. The last closing price for Ids was 0.49 €. Over the last year, Ids shares have traded in a share price range of 0.30 € to 0.68 €.

      Ids currently has 4,796,393 shares outstanding. The market capitalization of Ids is 2.35 € million. Ids has a price to earnings ratio (PE ratio) of -3.64.

      Ask ADVFN Intelligence (AI)

      MLIDS Latest News

      More News

      IDS RESULTATS 2023

      IDS RESULTATS 2023 COMMUNIQUE DE PRESSE / Le 20 Mai 2024         Résultats 2023 L’année 2023 a été une année de réorganisation, de restructuration et de redynamisation. Un nouveau Directeur...

      May 31 2024
      GlobeNewswire Inc.

      IDS RESULTATS 2020

      IDS RESULTATS 2020 COMMUNIQUE DE PRESSE / Le 7 Mai 2021          Résultats 2020 impactés par la crise sanitaire Le Conseil d’administration d’IDS s’est réuni le 5 mai 2021 et a arrêté les...

      May 07 2021
      GlobeNewswire Inc.

      IDS Résultats 2019 et Perspectives 2020

      IDS Résultats 2019 et Perspectives 2020 COMMUNIQUE DE PRESSE /  Le  5 Juin 2020             Résultats 2019 et Perspectives 2020 IDS a subi une baisse d’activité en 2019 principalement due aux...

      June 05 2020
      GlobeNewswire Inc.

      IDS SA : Résultats 2018 et Perspectives 2019

      COMMUNIQUE DE PRESSE -Le 18 Mars 2019 Résultats 2018 et Perspectives 2019 IDS a atteint de nouveau en 2018 un bon niveau d'activité conforme à ses performances structurelles avec une...

      March 20 2019
      GlobeNewswire

      IDS SA : Résultats 2017 et Perspectives 2018

      COMMUNIQUE DE PRESSE -Le 19 Juin 2018 Résultats 2017 et Perspectives 2018 L'activité de la Société a subi un net recul de 17 %. Sur son marché d'intégration et de production de données...

      June 19 2018
      GlobeNewswire

      IDS SA : Résultats 2015 et Perspectives 2016

      COMMUNIQUE DE PRESSE -Le 31 Mai 2016                                    Résultats 2015 et Perspectives 2016 L'exercice 2015 a été marqué par une stabilité accompagnée d'une forte...

      June 06 2016
      GlobeNewswire

      IDS SA : Résultats 2014 et Perspectives 2015

      COMMUNIQUE DE PRESSE -Le 17 Avril 2015Résultats 2014 et Perspectives 2015 L'exercice 2014 a été marqué par une compétition accrue sur les contrats d'intégration et de production de...

      April 20 2015
      GlobeNewswire

      IDS SA : Résultats 2013 et Perspectives 2014

        COMMUNIQUE DE PRESSE - Le 29 Avril 2014Résultats 2013 et Perspectives 2014 L'exercice 2013 a été marqué par une consolidation de l'activité d'IDS sur son métier...

      May 05 2014
      GlobeNewswire

      IDS SA : Résultats 2012 et Perspectives 2013

      body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  COMMUNIQUE DE PRESSE - Le 30 Mai 2013Résultats...

      June 03 2013
      GlobeNewswire

      IDS SA : Résultats 2012 et Perspectives 2013

      body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  COMMUNIQUE DE PRESSE - Le 30 Mai 2012 Résultats...

      June 03 2013
      GlobeNewswire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.490.490.4900DE
      40.11229.62962962960.3780.490.3782980.49DE
      120.1963.33333333330.30.50.33800.45049842DE
      260.17254.08805031450.3180.50.316350.39064495DE
      52-0.19-27.94117647060.680.680.310320.37561151DE
      156-0.11-18.33333333330.60.720.314730.55690915DE
      260-0.3-37.97468354430.790.9050.315200.61009979DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALRPDRapid Nutrition
      0.0746 €
      (28.18%)
      		15.67M
      ALOKWGroupe Okwind SA
      8.20 €
      (17.14%)
      		15.15k
      ALTHOMetavisio (Thomson Computing)
      0.397 €
      (16.42%)
      		1.34M
      IBABIon Beam Applications SA
      15.00 €
      (14.16%)
      		178.95k
      ALMEXMexedia SPA
      6.80 €
      (13.33%)
      		64
      MLWEYWeya
      0.02 €
      (-95.45%)
      		10
      ALAVEAventador
      0.001 €
      (-28.57%)
      		35.75M
      ALDVAlliance Developpement Capital Siic
      0.06 €
      (-19.46%)
      		280.26k
      GNROGeNeuro SA
      0.0724 €
      (-18.65%)
      		28.22k
      MLGRCGroupe Carnivor
      16.80 €
      (-16.00%)
      		12
      BCPBanco Comercial Portugues SA
      0.4333 €
      (3.51%)
      		141.92M
      ALAVEAventador
      0.001 €
      (-28.57%)
      		35.75M
      ALDOLDolfines
      0.0006 €
      (-14.29%)
      		29.46M
      ALRPDRapid Nutrition
      0.0746 €
      (28.18%)
      		15.67M
      ALNRGEnergisme SA
      0.0061 €
      (7.02%)
      		12.85M

      Discussion

      View Full Feed
      ssc ssc 3 minutes ago
      Spin, spin, spin. Twist, squirm, twist, squirm, twist squirm. Another new version of a worn out, unproven narrative filled with if's and would's. When management chooses to keep investors in the dark for 7 years, it's understandable why that's all ya got. That and 400 million shares at a price n
      ERHE
      CaptBeer CaptBeer 3 minutes ago
      Gotta love those Auzie's! Did you notice they changed the price from $154 to $32? That should sell like hotcakes!
      AMRN
      i_dont_know i_dont_know 3 minutes ago
      Interesting to see what his successor is doing if he gets the job in 20 years *lol*
      BLPG
      tredenwater2 tredenwater2 3 minutes ago
      My points are that companies applying for EMA and FDA approval typically have 2 properly powered P3 trials.

      Does proof of genomic activation and RNA data not help our trial data above and beyond the normal proof of work concept for what is statistically significant or not?
      AVXL
      Gmenfan Gmenfan 4 minutes ago
      Worthless... the word of the day for this administration.

      Actually the word every day!

      “Luxury shopping and now dinner at Nobu?” Rep. Dan Bishop (R-NC) told The Post in disbelief. “Mayorkas seems to care far more about keeping up with the Kardashians than any sort of
      Gmenfan Gmenfan 4 minutes ago
      Worthless... the word of the day for this administration.

      Actually the word every day!

      “Luxury shopping and now dinner at Nobu?” Rep. Dan Bishop (R-NC) told The Post in disbelief. “Mayorkas seems to care far more about keeping up with the Kardashians than any sort of
      getmoreshares getmoreshares 4 minutes ago
      this week info:UP 141.67%, pps gain 0.017
      ZHUD
      CaptBeer CaptBeer 5 minutes ago
      They would probably need a short bioequivalence trial similar to MARINE.
      AMRN
      Kap10jak Kap10jak 5 minutes ago
      If you pay 1 dollar for a stock and it splits the next day you have 2 shares and you only paid a dollar so each share cost you fitty cent. So to that guy you need to divide the original cost by number of splits to find out what he paid per share for all the shares he now owns.
      NWBO
      Gmenfan Gmenfan 6 minutes ago
      Herschel Walker to Barack Obama: ‘Telling Us to Vote Based on Color Is a Step Backward’
      WARNER TODD HUSTON 11 Oct 2024 3:03

      Former Georgia candidate for U.S. Senate Herschel Walker blasted Barack Obama for sending black people backward in equality by demanding they vote based o
      TheFinalCD TheFinalCD 7 minutes ago
      https://x.com/pulte/status/1845069073433923951
      Gmenfan Gmenfan 7 minutes ago
      Herschel Walker to Barack Obama: ‘Telling Us to Vote Based on Color Is a Step Backward’
      WARNER TODD HUSTON 11 Oct 2024 3:03

      Former Georgia candidate for U.S. Senate Herschel Walker blasted Barack Obama for sending black people backward in equality by demanding they vote based o
      getmoreshares getmoreshares 7 minutes ago
      why? too much feces on the streets?
      Gmenfan Gmenfan 8 minutes ago
      A worthless piece of shlt as is the rest the the current administration!
      VortexFortress8 VortexFortress8 9 minutes ago
      At least you are being honest..but i think rocks are a little too much for you..maybe you should go back to the powder..
      HIRU
      Gmenfan Gmenfan 10 minutes ago
      Hi Bull. Out of curiosity, what do you do with the fronds and the cut up chunks of trees?

      BTW that's quite an inventory of cordless power tools you have. I have many of the same but not as diverse of a collection.
      straightword straightword 10 minutes ago
      History shows that nothing will happen as a result of this. Get back to me when they get financial judgements that are in-line with the "billions and billions of ongoing" infringements that the CEO has spoken about. If not then it's a complete failure and confirmation that the patents aren't worth n
      VPLM
      sharpie510 sharpie510 11 minutes ago
      Thanks Doc logic. So what does this mean for when the clock started? Is the clock start date when validation happens (January 24, 2024) or when confirmation happens (March 7, 2024)?
      NWBO
      Investor082 Investor082 11 minutes ago
      Yup. Flaskworks carrot has been dangled so the social media army have conceded that no big pharma partnership is coming anytime soon!
      NWBO
      TrendTrade2016 TrendTrade2016 14 minutes ago
      TOO BAD YOU DON'T SHORT
      DWTX
      trunkmonk trunkmonk 14 minutes ago
      cant open and only have 1 post. any take away is appreciated.
      FNMA
      tm3141 tm3141 14 minutes ago
      it is available
      FNMA
      Investor082 Investor082 15 minutes ago
      Cant agree more. Given this history, it’s not surprising that no major institutional investors will ever touch this company. Always complaining!
      NWBO

      Your Recent History

      EU
      MLIDS
      Ids
      Delayed Upgrade Clock